Qiagen N.V. (ETR:QIA)

Market Cap	8.77B
Revenue (ttm)	1.85B
Net Income (ttm)	86.67M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	101.14
Forward PE	19.31
Dividend	1.21 (3.02%)
Ex-Dividend Date	Jan 29, 2025

Volume	42,074
Average Volume	620,132
Open	40.68
Previous Close	40.71
Day's Range	40.67 - 40.97
52-Week Range	34.24 - 47.36
Beta	0.67
RSI	68.27
Earnings Date	Jul 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD